ArticleEndocrine2019

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents.

Marcello Tucci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.